Home › Funds › Vanguard › Small Company Growth Portfolio
Fund family: Vanguard · Filed by VANGUARD VARIABLE INSURANCE FUNDS (CIK 857490) · SEC series S000004394
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 4,171 with, 28 against, 2 abstentions (not counted as with management); 4 items carried no recommendation; 8 split votes are in neither count. Shareholder proposals: 8 FOR, 15 AGAINST, 1 abstained, by the filing’s own vote-source field.
The same two figures as Vanguard’s manager page (1,379,791 ballot items across 136 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Vanguard | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 96.8% | 4,076 | 94.5% | 1,082,514 |
| Backed environmental and social shareholder proposals at US companies | n/a | 1 | 0.9% | 6,718 |
Each ballot item this fund voted is set against the votes of the other Vanguard funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Vanguard funds on 22 items (0.5% of the 4,057 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Vanguard funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Lattice Semiconductor Corporation | 2026-05-01 | To approve on a non-binding, advisory basis, our Named Executive Officer's compensation. | Against | FOR — 21 of 21 Vanguard funds | Against | Approved, 86.5% support |
| First American Financial Corporation | 2026-05-12 | Election of Class I director Nominees: Deborah L. Wahl | Against | FOR — 18 of 18 Vanguard funds | Against | Elected, 90.8% support |
| Tandem Diabetes Care, Inc. | 2026-05-20 | To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to, among other things, (i) limit the liability of officers of the Company to the maximum extent permitted by law as permitted pursuant to Section 102(b)(7) of the DGCL, and (ii) implement certain other change | Against | FOR — 17 of 17 Vanguard funds | For | Approved, 83.5% support |
| Tandem Diabetes Care, Inc. | 2026-05-20 | To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Christopher Twomey | Against | FOR — 17 of 17 Vanguard funds | For | Passed (calculated), 87.2% support |
| Viper Energy, Inc. | 2026-05-19 | Election of Directors: Laurie H. Argo | Against | FOR — 16 of 16 Vanguard funds | Against | Passed (calculated), 97.2% support |
| CarGurus, Inc. | 2026-06-03 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers for 2025. | Against | FOR — 25 of 26 Vanguard funds | Against | Approved, 94.3% support |
| ON Semiconductor Corporation | 2026-05-14 | To elect seven directors nominated by our Board of Directors: Christine Y. Yan | Against | FOR — 23 of 24 Vanguard funds | Against | Passed (calculated), 92.3% support |
| AAON, Inc. | 2026-05-12 | Election of Directors for a term ending in 2029: Stephen O. LeClair | Against | FOR — 15 of 15 Vanguard funds | Against | Passed (calculated), 87.1% support |
| Veracyte, Inc. | 2026-06-10 | The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Robert S. Epstein | Against | FOR — 15 of 15 Vanguard funds | Against | Elected, 93.0% support |
| Entegris, Inc. | 2026-05-06 | Shareholder Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. | For | AGAINST — 20 of 21 Vanguard funds | Against | Failed (calculated), 31.3% support |
| Entegris, Inc. | 2026-05-06 | Election of Directors: Azita Saleki-Gerhardt | Against | FOR — 20 of 21 Vanguard funds | Against | Passed (calculated), 95.7% support |
| Entegris, Inc. | 2026-05-06 | To approve, on an advisory basis, providing stockholders the right to call special meetings of stockholders. | Abstain | FOR — 20 of 21 Vanguard funds | Against | Passed (calculated), 83.6% support |
| The Timken Company | 2026-05-08 | Approval, on an advisory basis, of our named executive officer compensation. | Against | FOR — 26 of 28 Vanguard funds | Against | Approved, 74.6% support |
| Praxis Precision Medicines, Inc. | 2026-06-10 | To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William Young | Withhold | FOR — 13 of 14 Vanguard funds | Against | Passed (calculated), 85.5% support |
| Cimpress plc | 2025-12-17 | Reappoint Scott J. Vassalluzzo to Cimpress' Board of Directors to serve for a term of three years. | Against | FOR — 13 of 14 Vanguard funds | Against | Passed (calculated), 79.1% support |
| Aurora Innovation, Inc. | 2026-05-21 | Election of Directors: Gloria Boyland | Withhold | FOR — 14 of 16 Vanguard funds | Against | Elected, 97.3% support |
| The Timken Company | 2026-05-08 | Shareholder Consideration of a shareholder proposal asking our Board of Directors to take the steps necessary to amend the appropriate Company governing documents to give the owners of a combined 10% of our outstanding common stock the power to call a special shareholder meeting or the owners of the lowest perc | For | AGAINST — 17 of 22 Vanguard funds | Against | Not approved, 41.4% support |
| Lumexa Imaging Holdings, Inc. | 2026-06-10 | To elect three Class I directors to the Board of Directors, each to serve until the Company's 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal: Brian Regan | Withhold | FOR — 7 of 8 Vanguard funds | Against | — |
| Lumexa Imaging Holdings, Inc. | 2026-06-10 | To elect three Class I directors to the Board of Directors, each to serve until the Company's 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal: Caitlin Zulla | Withhold | FOR — 7 of 8 Vanguard funds | Against | — |
| Lumexa Imaging Holdings, Inc. | 2026-06-10 | To elect three Class I directors to the Board of Directors, each to serve until the Company's 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal: Lee Cooper | Withhold | FOR — 7 of 8 Vanguard funds | Against | — |
| Viper Energy, Inc. | 2026-05-19 | The approval of an amendment to the Company's certificate of incorporation to provide that stockholders holding at least 20% of the voting power, determined on a net long basis, continuously for at least one year, may call special meetings of stockholders, and other immaterial changes. | Against | FOR — 3 of 3 Vanguard funds | Against | Approved, 94.6% support |
| Trimble Inc. | 2026-05-26 | Elect Meaghan Lloyd | Withhold | FOR — 2 of 3 Vanguard funds | Against | — |
Download all 22 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 96.8% of this fund’s 4,201 such votes could be given a sector; the other 136 (3.2%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 975 | 4 | 0.4% |
| Consumer Discretionary | 904 | 9 | 1.0% |
| Technology | 809 | 3 | 0.4% |
| Industrials | 552 | 6 | 1.1% |
| Finance | 312 | 1 | 0.3% |
| Energy | 139 | 0 | 0.0% |
| Real Estate | 104 | 0 | 0.0% |
| Consumer Staples | 78 | 3 | 3.8% |
| Telecommunications | 70 | 1 | 1.4% |
| Miscellaneous | 45 | 0 | 0.0% |
| Utilities | 42 | 1 | 2.4% |
| Basic Materials | 35 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 2,871 | 3 |
| Say-on-Pay | 511 | 2 |
| Audit-related | 506 | 0 |
| Compensation | 174 | 0 |
| Corporate Governance | 105 | 15 |
| Capital Structure | 55 | 1 |
| Shareholder Rights and Defenses | 22 | 6 |
| Extraordinary Transactions | 18 | 0 |
| Diversity, Equity, and Inclusion | 1 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Axogen, Inc. | June 23, 2026 | $42M | 10 | 0 |
| Churchill Downs Incorporated | April 21, 2026 | $39M | 5 | 0 |
| Hinge Health, Inc. | June 3, 2026 | $38M | 3 | 0 |
| Bloom Energy Corporation | May 21, 2026 | $37M | 12 | 0 |
| Federal Signal Corporation | April 21, 2026 | $35M | 18 | 0 |
| Comfort Systems USA, Inc. | May 18, 2026 | $32M | 12 | 0 |
| Halozyme Therapeutics, Inc. | May 5, 2026 | $31M | 4 | 0 |
| Dynatrace, Inc. | August 20, 2025 | $31M | 8 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| April 30, 2026 | RB Global, Inc. | Approval Of A Special Resolution, Requiring The Company To Adopt A Policy And Amend Its Governing Documents Accordingly That All Shareholder Meetings Will Be Held In A Hybrid Format With Both In-Person And Virtual Access As Described In The Accompanying Proxy Statement. Shareholder proposal | Against | For |
| May 20, 2026 | Tandem Diabetes Care, Inc. | To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Christopher Twomey | Against | For |
| May 20, 2026 | Tandem Diabetes Care, Inc. | To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to, among other things, (i) limit the liability of officers of the Company to the maximum extent permitted by law as permitted pursuant to Section 102(b)(7) of the DGCL, and (ii) implement certain other changes based on updates to the DGCL. | Against | For |
| May 15, 2026 | Medpace Holdings, Inc. | Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting. Shareholder proposal | Against | For |
| May 6, 2026 | Entegris, Inc. | Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. Shareholder proposal | For | Against |
| January 22, 2026 | Jabil Inc. | Vote on a stockholder proposal requesting stockholder right to act by written consent. Shareholder proposal | Against | For |
| June 9, 2026 | Etsy, Inc. | Advisory vote on a stockholder proposal to govern by majority vote. Shareholder proposal | Against | For |
| May 8, 2026 | The Timken Company | Consideration of a shareholder proposal asking our Board of Directors to take the steps necessary to amend the appropriate Company governing documents to give the owners of a combined 10% of our outstanding common stock the power to call a special shareholder meeting or the owners of the lowest percentage of shareholders, as governed by state law, the power to call a special shareholder meeting. Shareholder proposal | For | Against |
| August 4, 2025 | Eagle Materials Inc. | Non-binding advisory stockholder proposal requesting the declassification of our Board of Directors. Shareholder proposal | For | Against |
| May 11, 2026 | MKS Inc. | A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. Shareholder proposal | Against | For |
| May 20, 2026 | Lumen Technologies, Inc. | Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. Shareholder proposal | Against | For |
| April 30, 2026 | NRG Energy, Inc. | To vote on a stockholder proposal to give shareholders the ability to call for a special shareholder meeting, if properly presented at the meeting. Shareholder proposal | For | Against |
Meetings with a proxy contest or competing nominees (2 in 2025-2026), and how the fund voted the items on its ballot.
4,263 ballot items at 525 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Small Company Growth Portfolio voted at 525 shareholder meetings of 515 companies, on 4,263 ballot items in all. Where management made a recommendation, the fund followed it on 99.3% of the items and voted against it 28 times. Its most frequent area of disagreement was corporate governance (15 of its votes against management). It voted on 26 shareholder proposals. It voted FOR the board's own proposals more often than Vanguard's funds as a whole (96.8% against 94.5%). It voted differently from most Vanguard funds on 22 items. 2 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Vanguard’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.